These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31971272)

  • 1. Tutorial on How the US Food and Drug Administration Regulates Parenteral Nutrition Products.
    Tabor E
    JPEN J Parenter Enteral Nutr; 2020 Feb; 44(2):174-181. PubMed ID: 31971272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Trace Element Supplementation for Parenteral Nutrition.
    Perks P; Huynh E; Kaluza K; Boullata JI
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation.
    Poole RL; Hintz SR; Mackenzie NI; Kerner JA
    JPEN J Parenter Enteral Nutr; 2008; 32(3):242-6. PubMed ID: 18443135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments.
    Skydel JJ; Luxkaranayagam AT; Dhruva SS; Ross JS; Wallach JD
    JAMA Netw Open; 2019 May; 2(5):e193410. PubMed ID: 31074812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
    Puthumana J; Miller JE; Kim J; Ross JS
    JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum content of parenteral nutrition in neonates: measured versus calculated levels.
    Poole RL; Schiff L; Hintz SR; Wong A; Mackenzie N; Kerner JA
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):208-11. PubMed ID: 20038851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The US Food and drug administration: drug information resource for formulary recommendations.
    Marchand HC; Ros BJ; Fine AM; Kremzner ME
    J Manag Care Pharm; 2012; 18(9):713-8. PubMed ID: 23206214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper and Zinc Deficiency in a Patient Receiving Long-Term Parenteral Nutrition During a Shortage of Parenteral Trace Element Products.
    Palm E; Dotson B
    JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):986-9. PubMed ID: 25189172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA.
    Hiayev S; Shacham-Shmueli E; Berkovitch M; Weiss I; Ashkenazi S; Vexberg MH; Hershkowitz R; Gorelik E; Mayan H; Steinmetz Y; Yanai NB; Schlissel O; Azem M; Gutgold N; Shulman K; Divinsky M; Yarom N; Vishkautzan A; Ganzel C; Gatt ME; Arcavi L; Marom E; Uziely B; Zevin S; Meirow H; Luxenburg O; Ainbinder D
    BMJ Open; 2023 May; 13(5):e067313. PubMed ID: 37142315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Drug Development: A Primer on the Food and Drug Administration.
    Purandare AV
    J Pediatric Infect Dis Soc; 2021 Nov; 10(10):977-981. PubMed ID: 34309662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral nutrition product shortages: the A.S.P.E.N. strategy.
    Mirtallo JM; Holcombe B; Kochevar M; Guenter P
    Nutr Clin Pract; 2012 Jun; 27(3):385-91. PubMed ID: 22513703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Shortages: Effect on Parenteral Nutrition Therapy.
    Holcombe B; Mattox TW; Plogsted S
    Nutr Clin Pract; 2018 Feb; 33(1):53-61. PubMed ID: 29365360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Call to Action to Bring Safer Parenteral Micronutrient Products to the U.S. Market.
    Vanek VW; Borum P; Buchman A; Fessler TA; Howard L; Shenkin A; Valentine CJ; ;
    Nutr Clin Pract; 2015 Aug; 30(4):559-69. PubMed ID: 26113560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
    Sacks LV; Shamsuddin HH; Yasinskaya YI; Bouri K; Lanthier ML; Sherman RE
    JAMA; 2014 Jan 22-29; 311(4):378-84. PubMed ID: 24449316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral nutrition product shortages: impact on safety.
    Holcombe B
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):44S-47S. PubMed ID: 22282871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales.
    Sharma D; Schumock GT; Saffore CD; Albert Edwards S; Walton SM
    Ther Innov Regul Sci; 2020 Mar; 54(2):424-430. PubMed ID: 32072591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition.
    Courtney-Martin G; Kosar C; Campbell A; Avitzur Y; Wales PW; Steinberg K; Harrison D; Chambers K
    JPEN J Parenter Enteral Nutr; 2015 Jul; 39(5):578-85. PubMed ID: 24743391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety concerns are important reasons why the FDA requires multiple reviews before approval of new drugs.
    Ross JS; Dzara K; Downing NS
    Health Aff (Millwood); 2015 Apr; 34(4):681-8. PubMed ID: 25847652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.